Su-hwan Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Robust neutralization of emerging JN.1 subvariants by the updated JN.1 vaccine: rationale for catch-up booster recommendations in high-risk individuals.
Journal: Frontiers in immunology
Published: September 01, 2025
Impaired and restored CD8+ T cell responses to a sequentially mutated spike epitope in Omicron variants.
Journal: Frontiers in immunology
Published: August 12, 2025
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study.
Journal: The Journal of infectious diseases
Published: August 29, 2024
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
Journal: Microbiology spectrum
Published: September 26, 2023
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
Journal: Journal of medical virology
Published: September 19, 2023
Longitudinal immune kinetics of COVID-19 booster versus primary series vaccination: Insight into the annual vaccination strategy.
Journal: Heliyon
Published: August 25, 2023
Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals.
Journal: The Journal of infection
Published: September 16, 2022
Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Journal: Frontiers in cellular and infection microbiology
Published: May 19, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026